ConductScience.org, home

Paper41978147

Protective Effects of Vitamin D Against Doxorubicin Chemotherapy-Induced Hepatotoxicity in Wistar Albino Rats: Evidence from 99mTc-Pyrophosphate Scintigraphy and Oxidative-Inflammatory Pathways.

Kalın M and 8 others. Nutrients, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Protective Effects of Vitamin D Against Doxorubicin Chemotherapy-Induced Hepatotoxicity in Wistar Albino Rats: Evidence from 99mTc-Pyrophosphate Scintigraphy and Oxidative-Inflammatory Pathways. Papers, record 41978147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41978147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protective Effects of Vitamin D Against Doxorubicin Chemotherapy-Induced Hepatotoxicity in Wistar Albino Rats: Evidence from 99mTc-Pyrophosphate Scintigraphy and Oxidative-Inflammatory Pathways.
PubMed
Journal
Nutrients
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kalın MMurat
2Karakullukcu HKHaluk Kerim
3Karakullukcu MMina
4Arslan AAylin
5Gül SSSerdar Savaş
6Toyran RReyhan
7Özkan ÖFÖmer Faruk
8Ercan GGülçin
9Aygun HHaticehttps://orcid.org/0000-0002-4272-0562

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Oxidative StressMajor topic
Chemical and Drug Induced Liver InjuryMajor topic
Vitamin DMajor topic
Antibiotics, AntineoplasticMajor topic
Animals
Rats, Wistar
Male
Liver
Rats
Radionuclide Imaging
Inflammation
Antioxidants
Biomarkers
Cholecalciferol

Source PubMed

Download CSV of topics

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128516789Protective effect of pravastatin on doxorubicin-induced hepatotoxicity.Bratisl Lek Listy2017https://conductscience.org/library/papers/28516789PubMed
238053572Nephroprotective effects of diminazene on doxorubicin-induced acute kidney injury in rats.Toxicol Rep2023https://conductscience.org/library/papers/38053572PubMed
338104651Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice.Am J Pathol2024https://conductscience.org/library/papers/38104651PubMed
432234491New molecular and biochemical insights of doxorubicin-induced hepatotoxicity.Life Sci2020https://conductscience.org/library/papers/32234491PubMed
538648220Doxorubicin causes cachexia, sarcopenia, and frailty characteristics in mice.PLoS One2024https://conductscience.org/library/papers/38648220PubMed
640602439NLRP3 inflammasome regulates doxorubicin-induced cardiotoxicity by modulating the abundance of gut microbiota.Toxicol Appl Pharmacol2025https://conductscience.org/library/papers/40602439PubMed
718694980Vitamin D and human health: lessons from vitamin D receptor null mice.Endocr Rev2008https://conductscience.org/library/papers/18694980PubMed
821048526Doxorubicin pathways: pharmacodynamics and adverse effects.Pharmacogenet Genomics2011https://conductscience.org/library/papers/21048526PubMed
930830277Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state.Eur J Appl Physiol2019https://conductscience.org/library/papers/30830277PubMed
1031600860Doxorubicin-induced skeletal muscle atrophy: Elucidating the underlying molecular pathways.Acta Physiol (Oxf)2020https://conductscience.org/library/papers/31600860PubMed
1133652780Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery.Antioxidants (Basel)2021https://conductscience.org/library/papers/33652780PubMed
1232384521The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis.Medicine (Baltimore)2020https://conductscience.org/library/papers/32384521PubMed
131834386Liver uptake of Tc-99m PYP.Clin Nucl Med1991https://conductscience.org/library/papers/1834386PubMed
1440319302Protective effects of Alamandine against doxorubicin-induced liver injury in rats.BMC Pharmacol Toxicol2025https://conductscience.org/library/papers/40319302PubMed
1540894204Doxorubicin-induced nephrotoxicity: the protective role of a standardized ethanolic extract of Andrographis paniculata leaves.Front Pharmacol2025https://conductscience.org/library/papers/40894204PubMed
1638796137Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric.Am J Kidney Dis2024https://conductscience.org/library/papers/38796137PubMed
1722596255The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.Endocr Rev2012https://conductscience.org/library/papers/22596255PubMed
1834092215CD36 deficiency ameliorates drug-induced acute liver injury in mice.Mol Med2021https://conductscience.org/library/papers/34092215PubMed
1918830610Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer.Int J Colorectal Dis2009https://conductscience.org/library/papers/18830610PubMed
2028718673Ameliorative Effect of Gallic Acid in Doxorubicin-Induced Hepatotoxicity in Wistar Rats Through Antioxidant Defense System.J Diet Suppl2018https://conductscience.org/library/papers/28718673PubMed

See all 71 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41978147

GET https://conductscience.org/api/papers/v1/41978147/references?page=2